Brevel Launches FOAK Facility to Demonstrate Microalgae Protein Fermentation at Commercial Scale
Israel’s Brevel, a biomass fermentation startup producing microalgae proteins, announces that it has completed the construction of its demonstration facility and secured two commercial agreements with leading F&B companies. The startup inaugurated a new site in Southern Israel this June, featuring headquarters, R&D space, and proprietary industrial-scale fermenters. The facility has been designed to implement a First-Of-A-Kind (FOAK) strategy to showcase the fermentation process at a commercial scale for the first time. With the FOAK strategy, Brevel aims to demonstrate that its fermentation technology is viable for real-world applications, reducing the perceived risk for investors, customers, and partners. “Once such validation is achieved, the focus shifts to operational and market challenges, significantly reducing overall risk,” Brevel comments. Collaborations to realize alt proteins Brevel says it has …